id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-E-0506-0007,FDA,FDA-2006-E-0506,Determination of Regulatory Review Period for Purposes of Patent Extension; NAMENDA,Notice,General Notice,2007-06-05T04:00:00Z,2007,6,2007-06-05T04:00:00Z,,2026-01-06T21:32:42Z,E7-10730,0,0,09000064804639a2
FDA-2006-E-0506-0006,FDA,FDA-2006-E-0506,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-05-17T04:00:00Z,2007,5,,,2026-01-06T21:27:05Z,,0,0,09000064804639a1
FDA-2006-E-0506-0005,FDA,FDA-2006-E-0506,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2007-03-08T05:00:00Z,2007,3,,,2026-01-06T21:20:13Z,,0,0,09000064804639a0
FDA-2006-E-0506-0003,FDA,FDA-2006-E-0506,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-01-26T05:00:00Z,2007,1,,,2026-01-06T21:00:58Z,,0,0,090000648046399e
FDA-2006-E-0506-0004,FDA,FDA-2006-E-0506,Letter for FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-01-26T05:00:00Z,2007,1,,,2026-01-06T21:09:19Z,,0,0,090000648046399f
FDA-2006-E-0506-0002,FDA,FDA-2006-E-0506,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-12-26T05:00:00Z,2006,12,,,2026-01-06T20:55:50Z,,0,0,090000648046399d
FDA-2006-E-0506-0001,FDA,FDA-2006-E-0506,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-12-26T05:00:00Z,2006,12,,,2026-01-06T20:53:27Z,,0,0,0900006480463997